Understanding GLP-1 Medications and Metabolism

This chapter explores the impact of GLP-1 receptor agonists on weight loss and appetite suppression among patients managing obesity and type 2 diabetes. It examines the metabolic adaptations that occur during weight loss, the role of calorie consumption accuracy, and the psychological aspects related to these treatments. Additionally, it compares terzepatide and semaglutide while addressing biological factors and emotional responses that influence eating behaviors.